Cullinan Oncology Inc. (CGEM) PT Raised to $27 at UBS
Tweet Send to a Friend
UBS analyst David Dai raised the price target on Cullinan Oncology Inc. (NASDAQ: CGEM) to $27.00 (from $24.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
